Ivelina Velikova, MBA

In securities class actions and other collective investor actions, Ms. Velikova has analyzed issues relating to class certification, market efficiency, traceability, price impact, materiality, loss causation, damages, and settlement in more than 100 matters brought under US, UK, Canadian, and Australian securities laws. Her experience also includes ERISA and derivative litigation. She has in-depth knowledge of the FDA drug approval process and the pharmaceutical and biotechnology industries. Her work spans a broad range of industries, including oil and gas, healthcare and pharmaceuticals, biotechnology, artificial intelligence, banking, insurance, entertainment, and real estate, and has involved accounting restatements, regulatory approvals, PIPE investments, securities offerings, and mergers and acquisitions.

Ms. Velikova also has extensive experience in breach of fiduciary duty class actions involving special purpose acquisition companies (SPACs) in the Delaware Court of Chancery. In these matters, she has evaluated market efficiency, assessed economic issues relating to materiality and loss causation through event study analysis, estimated aggregate class damages using company-specific market data and trading models, and conducted market and other analyses in connection with mediation and settlement.

In financial investigations, regulatory enforcement, and criminal matters, Ms. Velikova has opined on the price impact of information, analyzed allegations of insider trading and market manipulation, and estimated loss for sentencing purposes. She has also assessed damages and conducted market analyses in failed-bank litigation. In broker-customer disputes, she has evaluated portfolio concentration and leverage in customer investment portfolios containing equities, fixed-income securities, and funds; analyzed the performance and characteristics of municipal bonds, closed-end funds, and markets; and assessed damages and investment suitability.

In commercial and contract disputes, Ms. Velikova has assessed damages arising from breach of contract and professional malpractice claims. In consumer class actions, she has evaluated allegations of deceptive marketing and product defects and estimated associated damages. She also advises insurance brokers on litigation exposure under hypothetical scenarios in connection with D&O insurance coverage decisions and has worked on insurance coverage matters and evaluated the reasonableness of settlements in bankruptcy proceedings.